Match tier
Institution-verified
Presence
Current · Arkansas
Last published
2026
Sources
Institutional record
Refreshed
2026-08-15
M
Meenakshisundaram Balasubramaniam
Sourced from institutional research profiles (UAMS TRI or ARA).
High Impact
Assistant Professor
Also affiliated: United States Department of Veterans Affairs (2017); University of Arkansas Medical Center (2020–2024); Central Arkansas Veterans Healthcare System (2016–2024); Geriatric Research Education and Clinical Center (2017); Institute on Aging (2016–2025); John L. McClellan Memorial Veterans Hospital (2019); Reynolds American (United States) (2017); All India Institute of Medical Sciences (2024)
Faculty Researcher
23 h-index
56 pubs
1,289 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Meenakshisundaram Balasubramaniam's research focuses on the molecular mechanisms underlying neurodegenerative diseases, particularly Alzheimer's disease, and the development of potential therapeutic interventions. His work investigates protein aggregation, a hallmark of neurodegeneration, examining how misfolded proteins interact with cellular components like RNA and DNA. Balasubramaniam has explored the role of glial fibrillary acidic protein (GFAP) as a potential biomarker and therapeutic target for Alzheimer's disease, and has also studied the rescue of lysosomal autophagic failure in Alzheimer's disease models using small molecules.
His research also extends to other age-associated diseases and cellular processes. This includes investigating the role of mitochondria in aging and disease, and examining how conditions like myocardial infarction can induce endoplasmic reticulum stress and protein aggregation in both the heart and brain. Balasubramaniam leads a research group and has a significant publication record, with an h-index of 23 and over 1,200 citations. He collaborates with several researchers at the University of Arkansas for Medical Sciences, including Srinivas Ayyadevara and Robert J. Shmookler Reis.
Metrics
- h-index: 23
- Publications: 56
- Citations: 1,289
Selected Publications
-
Abstract LB320: Inverse relationship between cancer and Alzheimer’s disease: Important interplay between autophagy and apoptosis signaling mechanisms (2026)
-
Zolpidem restores sleep and decreases amyloid in a mouse model (2026)
-
The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease (2026)
-
Zolpidem restores sleep and slows Alzheimer’s progression in a mouse model (2025)
-
When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis (2025)
-
The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone (2025)
-
Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology (2025)
-
Abstract LB131: The role of the proinflammatory cytokine IL-1β and its signaling cascade in glioblastoma pathogenesis and the therapeutic effect of IL-1RA and Tolcapone as anticancer agents (2025)
-
Mitochondria in aging and age-associated diseases (2025)
-
Metabolomic Profiling and Machine Learning Models for Tumor Classification in Patients with Recurrent IDH-Wild-Type Glioblastoma: A Prospective Study (2024)
-
Tools of Artificial Intelligence in the Improvement of Synaptic Impairment in Different Neurodegenerative Diseases (2024)
-
Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)
-
Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities (2024)
-
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules (2024)
-
Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets (2023)
Grants & Funding
As listed on this researcher's institutional profile.
- Early Events in Alzheimer Pathogenesis NIH
- Neuroinflammation, Protein Aggregates, ApoE4 Drug Targeting, and Autophagy Rescue NIH
- Neuroinflammation, Protein Aggregates, ApoE4 Drug Targeting, and Autophagy Rescue NIH/Nat. Inst. on Aging
Collaboration Network
Top Collaborators
Srinivas Ayyadevara
University of Arkansas at Little Rock
17 shared publications
In database
- Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer’s disease
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Mitochondria in aging and age-associated diseases
Showing 5 of 17 shared publications
Robert J. Shmookler Reis
Institute on Aging
14 shared publications
In database
- Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer’s disease
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Mitochondria in aging and age-associated diseases
Showing 5 of 14 shared publications
Akshatha Ganne
University of Arkansas for Medical Sciences
14 shared publications
In database
- Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
Showing 5 of 14 shared publications
Nirjal Mainali
University of Arkansas at Little Rock
7 shared publications
In database
- Mitochondria in aging and age-associated diseases
- Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases
- Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets
Showing 5 of 7 shared publications
W. Sue T. Griffin
Central Arkansas Veterans Healthcare System
6 shared publications
In database
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease
- Abstract LB131: The role of the proinflammatory cytokine IL-1β and its signaling cascade in glioblastoma pathogenesis and the therapeutic effect of IL-1RA and Tolcapone as anticancer agents
- When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis
Showing 5 of 6 shared publications
Sonu Pahal
University of Arkansas at Little Rock
6 shared publications
In database
- Mitochondria in aging and age-associated diseases
- Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Tools of Artificial Intelligence in the Improvement of Synaptic Impairment in Different Neurodegenerative Diseases
- Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology
Showing 5 of 6 shared publications
Ramani Atluri
Central Arkansas Veterans Healthcare System
4 shared publications
In database
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
Narasimhappagari Jagadeesh
University of Arkansas for Medical Sciences
4 shared publications
In database
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone
- Abstract LB131: The role of the proinflammatory cytokine IL-1β and its signaling cascade in glioblastoma pathogenesis and the therapeutic effect of IL-1RA and Tolcapone as anticancer agents
- When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis
Orwa Aboud
Neurological Surgery
4 shared publications
In database
- Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities
- The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone
- Metabolomic Profiling and Machine Learning Models for Tumor Classification in Patients with Recurrent IDH-Wild-Type Glioblastoma: A Prospective Study
- Abstract LB131: The role of the proinflammatory cytokine IL-1β and its signaling cascade in glioblastoma pathogenesis and the therapeutic effect of IL-1RA and Tolcapone as anticancer agents
Narsimha Reddy Penthala
University of Arkansas for Medical Sciences
3 shared publications
In database
- Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer’s disease
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD)
Peter A. Crooks
University of Arkansas for Medical Sciences
3 shared publications
In database
- Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer’s disease
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD)
Haarika Ayyadevara
University of Arkansas at Fayetteville
3 shared publications
In database
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Lily Kiaei
University of California, Los Angeles (US)
2 shared publications
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Kottayil I. Varughese
University of Arkansas for Medical Sciences (US)
2 shared publications
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Mahmoud Kiaei
Arkansas Department of Agriculture
2 shared publications
In database
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Similar Researchers
Based on overlapping research topics
Chhanda Bose
University of Arkansas for Medical Sciences
Alzheimer's disease research and treatments
Mitochondrial Function and Pathology
Disease Mechanisms Research
Steven W. Barger
University of Arkansas for Medical Sciences
Alzheimer's disease research and treatments
Mitochondrial Function and Pathology
Disease Mechanisms Research
Srinivas Ayyadevara
University of Arkansas for Medical Sciences
Alzheimer's disease research and treatments
Protein Structure and Dynamics
Mitochondrial Function and Pathology
Matthew S. Boone
University of Arkansas for Medical Sciences
Protein Structure and Dynamics
Disease Mechanisms Research
Neurological disorders and treatments
Sanjana Padala
National Center for Toxicological Research
Alzheimer's disease research and treatments
Disease Mechanisms Research
Neurological disorders and treatments
Benjamin May
University of Arkansas for Medical Sciences
Protein Structure and Dynamics
Mitochondrial Function and Pathology
Disease Mechanisms Research